Early research (Phase 1)Looking for participantsNCT07289477
What this trial is testing
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd. 9